# Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test

> **NCT05771714** · NA · TERMINATED · sponsor: **AccessBio, Inc.** · enrollment: 786 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** CareSuperb COVID-19 Antigen Home Test Kit

## Key facts

- **NCT ID:** NCT05771714
- **Lead sponsor:** AccessBio, Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-01-09
- **Primary completion:** 2023-05-11
- **Final completion:** 2023-05-11
- **Target enrollment:** 786 (ACTUAL)
- **Why stopped:** Cancel study
- **Last updated:** 2023-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05771714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05771714, "Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05771714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*